-
2
-
-
0034950031
-
-
Matsuda H., Kageura T., Oda M., Morikawa T., Sakamoto Y., and Yoshikawa M. Chem. Pharm. Bull. 49 (2001) 716
-
(2001)
Chem. Pharm. Bull.
, vol.49
, pp. 716
-
-
Matsuda, H.1
Kageura, T.2
Oda, M.3
Morikawa, T.4
Sakamoto, Y.5
Yoshikawa, M.6
-
3
-
-
0041881635
-
-
Liou K.-T., Shen Y.-C., Chen C.-F., Tsao C.-M., and Tsai S.-K. Eur. J. Pharmacol. 475 (2003) 19
-
(2003)
Eur. J. Pharmacol.
, vol.475
, pp. 19
-
-
Liou, K.-T.1
Shen, Y.-C.2
Chen, C.-F.3
Tsao, C.-M.4
Tsai, S.-K.5
-
4
-
-
26944444312
-
-
Tse K.-W., Wan C.-K., Shen X.-L., Yang M., and Fong W.-F. Biochem. Pharmacol. 70 (2005) 1443
-
(2005)
Biochem. Pharmacol.
, vol.70
, pp. 1443
-
-
Tse, K.-W.1
Wan, C.-K.2
Shen, X.-L.3
Yang, M.4
Fong, W.-F.5
-
5
-
-
34447320192
-
-
Amblard F., Govindarajan B., Lefkove B., Rapp K.L., Detorio M., Arbiser J.L., and Schinazi R.F. Bioorg. Med. Chem. Lett. 17 (2007) 4428
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 4428
-
-
Amblard, F.1
Govindarajan, B.2
Lefkove, B.3
Rapp, K.L.4
Detorio, M.5
Arbiser, J.L.6
Schinazi, R.F.7
-
6
-
-
0037156332
-
-
Fukuyama Y., Nakade K., Minoshima Y., Yokoyama R., Zhai H., and Mitsumoto Y. Bioorg. Med. Chem. Lett. 12 (2002) 1163
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 1163
-
-
Fukuyama, Y.1
Nakade, K.2
Minoshima, Y.3
Yokoyama, R.4
Zhai, H.5
Mitsumoto, Y.6
-
7
-
-
1942502419
-
-
and references cited therein
-
Esumi T., Makado G., Zhai H., Shimizu Y., Mitsumotob Y., and Fukuyama Y. Bioorg. Med. Chem. Lett. 14 (2004) 2621 and references cited therein
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 2621
-
-
Esumi, T.1
Makado, G.2
Zhai, H.3
Shimizu, Y.4
Mitsumotob, Y.5
Fukuyama, Y.6
-
9
-
-
0003899196
-
-
For recent reviews of Suzuki-Miyaura coupling see:, Springer, Berlin
-
For recent reviews of Suzuki-Miyaura coupling see:. Miyaura N. Organoboron compounds Cross-Coupling Reaction A Practical Guide. Topics in Current Chemistry Vol. 219 (2002), Springer, Berlin
-
(2002)
Topics in Current Chemistry
, vol.219
-
-
Miyaura, N.1
-
12
-
-
4344610661
-
-
For recent reviews of Claisen rearrangement see:
-
For recent reviews of Claisen rearrangement see:. Castro A.M.M. Chem. Rev. 104 (2004) 2939
-
(2004)
Chem. Rev.
, vol.104
, pp. 2939
-
-
Castro, A.M.M.1
-
16
-
-
34250722048
-
-
Johnson J.B., Bercot E.A., Williams C.M., and Rovis T. Angew. Chem., Int. Ed. 46 (2007) 4514
-
(2007)
Angew. Chem., Int. Ed.
, vol.46
, pp. 4514
-
-
Johnson, J.B.1
Bercot, E.A.2
Williams, C.M.3
Rovis, T.4
-
17
-
-
0028054343
-
-
Larsen R.D., King A.O., Chen C.Y., Corley E.G., Foster B.S., Roberts F.E., Yang C., Lieberman D.R., Reamer R.A., Tschaen D.M., Verhoeven T.R., and Reider P.J. J. Org. Chem. 59 (1994) 6391
-
(1994)
J. Org. Chem.
, vol.59
, pp. 6391
-
-
Larsen, R.D.1
King, A.O.2
Chen, C.Y.3
Corley, E.G.4
Foster, B.S.5
Roberts, F.E.6
Yang, C.7
Lieberman, D.R.8
Reamer, R.A.9
Tschaen, D.M.10
Verhoeven, T.R.11
Reider, P.J.12
-
18
-
-
36549035187
-
-
Pan C., Liu M., Zhang L., Wu H., Ding J., and Cheng J. Catal. Commun. 9 (2008) 508
-
(2008)
Catal. Commun.
, vol.9
, pp. 508
-
-
Pan, C.1
Liu, M.2
Zhang, L.3
Wu, H.4
Ding, J.5
Cheng, J.6
-
22
-
-
58349112461
-
-
note
-
f 0.45). The desired product, 5-allyl-2-methoxybiphenyl-4′-ol, was obtained as oil (26 mg, 83%).
-
-
-
|